Thomas Marron
Clinical trials sponsored by Thomas Marron, explained in plain language.
-
New drug cocktail aims to revive immunotherapy in tough lung cancers
Disease control OngoingThis early-stage trial tests whether adding two anti-inflammatory drugs (dupilumab and anakinra) to standard immunotherapy can help shrink tumors in people with advanced non-small cell lung cancer that has stopped responding to prior immunotherapy. About 33 adults will receive th…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated May 17, 2026 02:19 UTC
-
Could a common HIV drug help fight resistant cancers?
Disease control OngoingThis early-phase study tests whether adding lamivudine, an HIV medication, can help control advanced solid tumors that no longer respond to standard immunotherapy. About 12 adults with various solid cancers will receive lamivudine alongside their current immunotherapy. The goal i…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated May 08, 2026 12:02 UTC